129 related articles for article (PubMed ID: 36301646)
1. Perinatal Outcomes Associated With Institutional Changes Early in the COVID-19 Pandemic.
Racine JL; Hetzel SJ; Iruretagoyena JI; Hoppe KK
WMJ; 2022 Oct; 121(3):201-204. PubMed ID: 36301646
[TBL] [Abstract][Full Text] [Related]
2. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.
Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471
[TBL] [Abstract][Full Text] [Related]
3. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
[TBL] [Abstract][Full Text] [Related]
4. Impact of labor and delivery unit policy modifications on maternal and neonatal outcomes during the coronavirus disease 2019 pandemic.
Greene NH; Kilpatrick SJ; Wong MS; Ozimek JA; Naqvi M
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100234. PubMed ID: 32984804
[TBL] [Abstract][Full Text] [Related]
5. Maternal and neonatal outcomes of elective induction of labor.
Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
[TBL] [Abstract][Full Text] [Related]
6. Changes in obstetrical practices and pregnancy outcomes following the ARRIVE trial.
Gilroy LC; Al-Kouatly HB; Minkoff HL; McLaren RA
Am J Obstet Gynecol; 2022 May; 226(5):716.e1-716.e12. PubMed ID: 35139334
[TBL] [Abstract][Full Text] [Related]
7. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
[TBL] [Abstract][Full Text] [Related]
8. An hypothetical external validation of the ARRIVE trial in a European academic hospital.
Tassis BMG; Ruggiero M; Ronchi A; Ramezzana IG; Bischetti G; Iurlaro E; D'Ambrosi F; Ciralli F; Mosca F; Ferrazzi EM
J Matern Fetal Neonatal Med; 2022 Nov; 35(22):4291-4298. PubMed ID: 33207972
[TBL] [Abstract][Full Text] [Related]
9. Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.
Alkmark M; Keulen JKJ; Kortekaas JC; Bergh C; van Dillen J; Duijnhoven RG; Hagberg H; Mol BW; Molin M; van der Post JAM; Saltvedt S; Wikström AK; Wennerholm UB; de Miranda E
PLoS Med; 2020 Dec; 17(12):e1003436. PubMed ID: 33290410
[TBL] [Abstract][Full Text] [Related]
10. Effects of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial on Elective Induction and Obstetric Outcomes in Term Nulliparous Patients.
Nethery E; Levy B; McLean K; Sitcov K; Souter VL
Obstet Gynecol; 2023 Aug; 142(2):242-250. PubMed ID: 37411030
[TBL] [Abstract][Full Text] [Related]
11. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta-analysis.
Sotiriadis A; Petousis S; Thilaganathan B; Figueras F; Martins WP; Odibo AO; Dinas K; Hyett J
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):26-35. PubMed ID: 30298532
[TBL] [Abstract][Full Text] [Related]
12. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.
Biesty LM; Egan AM; Dunne F; Dempsey E; Meskell P; Smith V; Ni Bhuinneain GM; Devane D
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012910. PubMed ID: 29303230
[TBL] [Abstract][Full Text] [Related]
13. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies.
Grobman WA; Caughey AB
Am J Obstet Gynecol; 2019 Oct; 221(4):304-310. PubMed ID: 30817905
[TBL] [Abstract][Full Text] [Related]
14. Maternal and newborn outcomes with elective induction of labor at term.
Souter V; Painter I; Sitcov K; Caughey AB
Am J Obstet Gynecol; 2019 Mar; 220(3):273.e1-273.e11. PubMed ID: 30716284
[TBL] [Abstract][Full Text] [Related]
15. Elective Induction of Labor in the 39th Week of Gestation Compared With Expectant Management of Low-Risk Multiparous Women.
Sinkey RG; Blanchard CT; Szychowski JM; Ausbeck E; Subramaniam A; Neely CL; Casey BM; Tita AT
Obstet Gynecol; 2019 Aug; 134(2):282-287. PubMed ID: 31306328
[TBL] [Abstract][Full Text] [Related]
16. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of elective induction of labour compared with expectant management: population based study.
Stock SJ; Ferguson E; Duffy A; Ford I; Chalmers J; Norman JE
BMJ; 2012 May; 344():e2838. PubMed ID: 22577197
[TBL] [Abstract][Full Text] [Related]
18. Obstetric Racial Disparities in the Era of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial and the Coronavirus Disease 2019 (COVID-19) Pandemic.
Wheeler SM; Truong T; Unnithan S; Hong H; Myers E; Swamy GK
Obstet Gynecol; 2024 May; 143(5):690-699. PubMed ID: 38547489
[TBL] [Abstract][Full Text] [Related]
19. Does induction of labor at term increase the risk of cesarean section in advanced maternal age? A systematic review and meta-analysis.
Fonseca MJ; Santos F; Afreixo V; Silva IS; Almeida MDC
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():213-219. PubMed ID: 32889327
[TBL] [Abstract][Full Text] [Related]
20. A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies.
Gibson KS; Waters TP; Bailit JL
Am J Obstet Gynecol; 2016 Mar; 214(3):389.e1-389.e12. PubMed ID: 26440691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
